tirzepatide surpass trials Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the Clinical Trial Program | Cardiovascular Diabetology Efficacy and Safety of Tirzepatide

Pittman of the US District Court for the Northern District of Texas denied Thursday a motion for preliminary injunction from the Outsourcing Facilities Association and FarmaKeio Custom Compounding that would have blocked the Food and Drug Administration from enforcement while a lawsuit unfolds

Optimize GLP-1 Medication Usage Another way to break through a plateau could be by changing up your GLP-1 medication

If loose skin extends around the waist and back, an isolated tummy tuck may not be the most complete option

The interaction between exercise and GLP-1 therapy is an active area of investigation

Structured strength training, and 1.2 to 1.6 grams of protein per kilo of body weight per day

Peptides, 12:861-863